07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

MANT<br />

8773<br />

MANN<br />

8772<br />

5 50.0-99.9 Strongly positive<br />

6 > or =100 Strongly positive Reference values<br />

apply to all ages.<br />

Clinical References: Homburger HA: Allergic diseases. In Clinical Diagnosis and Management by<br />

Laboratory Methods. 21st edition. Edited by McPherson RA, Pincus MR. WB Saunders, Publ, New York,<br />

Chapter 53, Part VI, pp. 961-971, 2007<br />

Alpha-Mannosidase, Fibroblasts<br />

Clinical Information: Alpha-mannosidosis is an autosomal recessive lysosomal storage disorder<br />

caused by reduced or absent acid alpha-mannosidase enzyme activity. This enzyme is involved in<br />

glycoprotein catabolism, with absent or reduced activity resulting in the accumulation of undigested<br />

mannose-containing complex oligosaccharides in the lysosomes. This eventually interferes with the<br />

normal functioning of cells. Clinical features and severity of symptoms are widely variable within<br />

alpha-mannosidosis, but in general, the disorder is characterized by skeletal abnormalities, immune<br />

deficiency, hearing impairment, and mental retardation. Three clinical subtypes of the disorder have been<br />

described and they vary with respect to age of onset and clinical presentation. Type 1 is generally<br />

classified by a mild presentation and slow progression with onset after 10 years of age and absence of<br />

skeletal abnormalities. Type 2 is generally a more moderate form with slow progression and onset prior to<br />

10 years of age with skeletal abnormalities and myopathy. Type 3 is the most severe form and usually<br />

presents with prenatal loss or severe central nervous system involvement leading to an early death. The<br />

incidence of alpha-mannosidosis is estimated at 1 in 500,000 live births. A diagnostic work up for<br />

alpha-mannosidosis may demonstrate slight elevations of oligosaccharides in urine (OLIGO/84340<br />

Oligosaccharide Screen, Urine). Reduced or absent enzyme activity of acid alpha-mannosidase in<br />

leukocytes can confirm a diagnosis. Sequencing of the MAN2B1 gene allows for detection of<br />

disease-causing mutations in affected patients and identification of familial mutations allows for testing of<br />

at-risk family members.<br />

Useful For: Diagnosis of alpha-mannosidosis<br />

Interpretation: Values

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!